EuroBiotechNews
UK 1. January 1970
24.07.2009 Novi Sad/London - EU-funded researchers have identified the genes that allow insects called Arctic springtails to survive temperatures as low as -14°C. 'This is the first in-depth molecular study on the underlying cold survival mechanisms in... more
UK 1. January 1970
.... Under the terms of the collaboration with GSK’s Centre of Excellence for External Drug Discovery (CEEDD) in Stevenage (UK... more
UK 1. January 1970
... Department of Plant Sciences at the University of Cambridge, UK. "Salinity affects the growth of plants worldwide... more
UK 1. January 1970
... ” will help the UK capitalise fully on its leading global position in regenerative medicine. The OLS... ’ blueprint sets out to transform the UK environment for life sciences companies and ensure faster patient access to cutting-edge medicines and technologies... more
UK 1. January 1970
14.07.2009 Brussels/London – According to market researchers from Datamonitor, the biosimilar market is set to expand rapidly. The business analysis group says that by 2014, revenues in the 7 major pharmaceutical markets will hit the US$2bn mark... more
UK 1. January 1970
12.07.2009 London – Sir Tom Blundell will succeed Dr. Peter Ringrose as Chair of the Biotechnology and Biological Sciences Research Council (BBSRC), the UK‘s funding agency for research in the life sciences that annually invests around £450... more
Germany 1. January 1970
... % returns, in many cases even without relevant news-flow. This happened especially in the UK and Norway, where performance lagged last year compared to the rest of Europe... more
Germany 1. January 1970
.... UK stem cell pioneer Stephen Minger said that the lift of the ban could easily support a brain drain from Europe to the US... more
BioFunding, UK 1. January 1970
25.01.2007 London – The British pharmaceutical company Protherics plc has issued 58 715 544 new ordinary shares for Euro 54 million to finance the company’s growth. Only recently, Protherics had acquired the US firm Macromed Inc. in... more
UK 1. January 1970
11.07.2009 Patient accrual is a function of the total accumulated recruitment time (the sum of the country/site-specific active recruitment period across all sites) and the rate at which each site recruits patients. Recruitment planning must take into... more
Previous page 1/38 Next page
© 2007-2013 BIOCOM
http://www.eurobiotechnews.eu/service/suche-ebsin.html
the Wyss Institute for Biologically Inspired Engineering at Harvard University and Sony DADC announced a collaboration that will harness Sony DADC’s global manufacturing expertise to further advance the Institute’s Organs-on-Chips technologies. more
